Related Experiment Videos
Ventriculoperitoneal shunt-associated infection due to Haemophilus influenzae
Insights
Treating Haemophilus influenzae type b (Hib) ventriculoperitoneal shunt infections requires careful consideration. Prompt sterilization of cerebrospinal fluid and clinical improvement are key factors in determining the need for shunt removal alongside antimicrobial therapy.
Area of Science:
- Pediatric Infectious Diseases
- Neurosurgery
- Microbiology
Background:
- Ventriculoperitoneal shunts are crucial for managing hydrocephalus in children.
- Infections, particularly by Haemophilus influenzae type b (Hib), pose significant challenges in shunt management.
- Effective treatment strategies for Hib shunt infections are critical to prevent neurological complications.
Observation:
- Two pediatric cases of ventriculoperitoneal shunt infection caused by Haemophilus influenzae type b (Hib) were analyzed.
- One patient achieved cure with systemic and intraventricular antimicrobial therapy alone.
- The second patient experienced persistent positive ventricular fluid cultures, necessitating shunt removal and antimicrobial therapy, followed by a relapse responsive to antimicrobials alone.
Findings:
- Prompt sterilization of ventricular fluid and clinical improvement guide treatment decisions for Hib shunt infections.
- Shunt removal may be required in cases with persistent infection despite initial antimicrobial treatment.
- Systemic antimicrobial therapy for two to four weeks is recommended for managing these infections.
Implications:
- Early and aggressive management, potentially including shunt removal, is vital for successful outcomes in pediatric Hib shunt infections.
- This study highlights the importance of individualized treatment approaches based on patient response and microbiological data.
- Further research into optimal antimicrobial regimens and the role of shunt intervention in Hib meningitis is warranted.
Abstract:
We report two children with ventriculoperitoneal shunt infections due to Haemophilus influenzae, type b. One child was cured with systemic and intraventricular antimicrobial therapy alone. The other child had persistently positive ventricular fluid cultures, ultimately required shunt removal in addition to antimicrobial therapy, and still had a relapse, which responded to antimicrobial therapy alone. In treating children with this problem we recommend removal of the shunt apparatus unless there is prompt sterilization of ventricular fluid and clinical improvement. Systemic antimicrobial therapy should be continued for two to four weeks.